36
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Clinicopathological Analysis of Follicular Lymphoma with a Polyploid Karyotype

, , , , , & show all
Pages 383-389 | Received 20 Jan 1997, Accepted 03 Apr 1997, Published online: 01 Jul 2009

References

  • Yunis J. J., Oken M. M., Kaplan M. E., Ensrud K. M., Howe R. B., Theologides A. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. New England Journal of Medicine 1982; 307: 1231–1236
  • Tilly H., Rossi A., Stamatoullas A., Lenormand B., Bigorgne C., Kunlin A., Monconduit M., Bastard C. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 1994; 84: 1043–1049
  • Coiffier B., Bastion Y., Berger F., Felman P., Bryon P. A. Prognostic factors in follicular lymphoma. Seminars in Oncology 1993; 20(suppl 5)89–95
  • McLaughlin P., Osborne B. M., Johnston D., Jennings P., Butler J. J., Cabanillas F., Barlogie B. Nucleic acid flow cytometry in large cell lymphoma. Cancer Research 1988; 48: 6614–6619
  • Macartney J. C., Camplejohn R. S., Morris R., Hollowood K., Clarke D., Timothy A. DNA flow cytometry of follicular non-Hodgkin's lymphoma. Journal of Clinical Pathology 1991; 44: 215–218
  • Joensuu H., Klemi P. J., Jalkanen S. Biologic progression in non-Hodgkin's lymphoma. A flow cytometric study. Cancer 1990; 65: 2564–2571
  • Lehtinen T., Aine R., Lehtinen M., Kallioniemi O-P., Leino T., Hakala T., Leinikki P., Alavaikko M. Flow cytometric DNA analysis of 199 histologically favourable or unfavourable non-Hodgkin lymphomas. Journal of Pathology 1989; 157: 27–36
  • De Lena M., Barletta A., Marzullo F., Lorusso V., Berard F., Tommasi S., Mangia A., Paradiso A. Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomas. Haematologica 1992; 11: 84–86
  • Obeso G., Sanz E. R., Rivas C., Marcos B., Garcia-Delgado R., Echezarreta G., Benitez J., Montalban C., Castrillo J. M. B-cell follicular lymphomas: clinical and biological characteristics. Leukemia & Lymphoma 1994; 16: 105–111
  • Marcos B., Echezarreta G., Rivas C., Garcia R., Sanz E., Obeso G., Bueno A., Gonzalo I., Sarasa J. L. Biologia de los linfomas B del foliculo nodal secundario. Un estudio pato-dinamico [Biology of secondary nodal follicular B-lymphomas. A patho-dynamic study], [Review][Spanish]. Sangre 1993; 38: 435–441
  • Rehn S., Glimelius B., Strang P., Sundstrom C., Tribukait B. Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma. Hematological Oncology 1990; 2: 269–306
  • Wu H. Prognostic Significance of DNA Flow Cytometry in Non-Hodgkin's Lymphoma. Journal of Tongji Medical University 1992; 12: 65–70
  • Winter J. N., Andersen J., Variakojis D., Gordon L. I., Fisher R. I., Oken M. M., Neiman R. S., Jiang S., Bauer K. D. Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomas. Blood 1996; 88: 3919–3925
  • Offit K., Wong G., Filippa D. A., Tao Y., Chaganti R. S. K. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. Blood 1991; 11: 1508–1515
  • Kristofferson U., Heim S., Mandahl N., Olsson H., Ranstam J., Akerman M., Mitelman F. Prognostic implication of cytogenetic findings in 106 patients with non-Hodgkin lymphoma. Cancer Genetics and Cytogenetics 1987; 25: 55–64
  • ISCN. An International System for Human Cytogenetic Nomenclature, F. Mitelman. S. Karger, Basel 1995
  • The Non-Hodgkin's Pathologic Classification Project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphoma: Summary and description of a Working Formulation for Clinical Usage. Cancer 1982; 49: 2112–2135
  • Mann R. B., Berard C. W. Criteria for the cytologic subclassification of follicular lymphomas: A proposed alternative method. Hematological Oncology 1983; 1: 187–192
  • Armitage P. Statistical Methods in Medical Research4th edn. Blackwell Scientific, London 1977
  • Kaplan E. L., Meier P. Nonparametric estimation for incomplete observations. Journal of the American Statistics Association 1958; 53: 457–481
  • Peto R., Pike M. C., Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. British Journal of Cancer 1977; 35: 1–39
  • Shipp M. A., Harrington D. P., Anderson J. R., Bonadonna G., Brittinger G., Cabanillas F., Canellos G. P., Coiffer B., Connors J. M., Cowan R. A., Crowther D., Dahlberg S., Engelhard M., Fisher R. I., Gisselbrecht C., Horning S. J., Lepage E., Lister A., Meerwaldt J. H., Montserrat E., Nissen N. I., Oken M. M., Peterson B. A., Tondini C., Velasquez W. S., Yeap B. Y. A predictive model for aggressive NHL: The international non-Hodgkin's lymphoma prognostic factors project. New England Journal of Medicine 1993; 329: 987–994
  • Shackney S. E., Smith C. A., Miller B. W., Burholt D. R., Murtha K., Giles H. R., Ketterer D. M., Pollice A. A. Model for the genetic evolution of human solid tumors. Cancer Research 1989; 49: 3344–3354
  • Terzi M. Chromosomal variation and the origin of drug-resistant mutants in mammalian cell lines. Proceedings of the National Academy of Sciences USA 1971; 71: 5027–5031
  • Stanbridge E. J., Der C. J., Doersen C., Nishimi R. Y., Peehl D. M., Weissman B. E., Wilkison J. E. Human cell hybrids: analysis of transformation and tumorigenicity. Science 1982; 215: 252–259
  • Lakkala T., Laasonen A., Fransilla K., Teerenhovi L., Knuutila S. Comparison of DNA and karyotype ane-uploidy in malignant lymphomas. American Journal of Clinical Pathology 1990; 94: 600–605
  • Cabanillas F., Trujillo J. M., Barlogie B., McLaughlin P., Cork A., Butler J. J., Manning J. T., Riggs S. A. Chromosomal abnormalities in lymphoma and their correlations with nucleic acid flow cytometry. Cancer Genetics and Cytogenetics 1986; 21: 99–106
  • Grierson H., Wooldridge T. N., Hess M., Wooldridge L., Ratashak A., Bast M., Armitage J. O., Weisenburger D. D., Sanger W. G. Comparison of DNA content in non-Hodgkin's lymphoma as measured by flow cytometry and cytogenetics. Cancer Genetics and Cytogenetics 1995; 80: 124–128

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.